Nav: Home

Ultrasound method restores dopaminergic pathway in brain at Parkinson's early stages

June 06, 2019

New York, NY--June 6, 2019--While there are several thousand drugs available to treat a wide range of brain diseases, from depression to schizophrenia, they cannot penetrate the blood-brain barrier (BBB) into the brain. The BBB, which protects the brain from pathogens that may be present in blood, also prevents most drugs from gaining access to the brain functional tissue, the parenchyma, a well-known challenge to the treatment of all brain diseases including neurodegenerative disorders like Parkinson's disease and Alzheimer's.

A team led by Elisa Konofagou, Robert and Margaret Hariri Professor of Biomedical Engineering and Professor of Radiology (Physics) at Columbia Engineering, has been developing a novel technique that could open up new ways to facilitate targeted drug delivery into the brain and enable drugs to treat brain diseases more focally. The researchers used transcranial, focused ultrasound and intravenously injected microbubbles into the BBB to make a localized and transient opening that allows drugs to cross through the BBB reversibly and non-invasively. Focusing on Parkinson's disease, in collaboration with Serge Przedborski's group in the department of neurology at Columbia University Irving Medical Center, they discovered that protein delivery and gene delivery across the BBB can partly restore the dopaminergic pathways, the neurons in the brain that are affected in early Parkinson's disease.

"We found both behavioral and anatomical neuronal improvements in the brain," says Konofagou, who led the study, published online on April 4 by the Journal of Controlled Release, and in print June 10. "This is the first time that anyone has been able to restore a dopaminergic pathway with available drugs at the early stages of Parkinson's disease. We were able to curb the rapid progression of neurodegeneration while improving the neuronal function. We expect our study will open new therapeutic avenues for the early treatment of central nervous system diseases."

The team targeted the brain regions involved in early stage Parkinson's and Alzheimer's disease, such as the putamen and hippocampus. The tool they developed for the study is a device that uses a neuronavigation system to direct the treatment in real-time. The U.S. FDA has just assigned the team an Investigational Device Exemption (IDE) to use the device in clinical trials to test its safety in Alzheimer's patients.

"Neurosurgeons use such systems all the time to guide them for neurosurgery," says Antonios Pouliopoulos, associate research scientist in Konofagou's lab who worked on the development of the clinical neuronavigation system. "Our group just replaced the surgical instrument with an ultrasound transducer to perform our non-invasive procedure."

Konofagou's Ultrasound Elasticity and Imaging Laboratory is the only academic lab in the U.S. to receive FDA approval for ultrasound-assisted, blood-brain-barrier opening. Other groups doing similar research either use nanoparticles to facilitate drug delivery or require MRI to guide the procedure. Konofagou's approach is MRI-independent and does not require any nanoparticles.

Her device is a single-element transducer that is much smaller, faster, and less expensive than current helmet-shaped, 1024-element transducer systems that use MRI guidance. Because Konofagou's system is portable, doctors will be able to treat patients anywhere in a hospital and, in the future, even at a patient's home. Treatment can be completed in less than 30 minutes, compared to three to four hours for MRI-guided therapy, and monitored in real-time, a unique feature of the new device. The cost is 10 times less than the MRI-guided helmet. The first trial with the device will be with Alzheimer's patients, after which Konofagou plans to work with Parkinson's patients.

Konafagou recently won a four-year $2.5M NIH grant to use a similar device for deep brain stimulation aiming to unveil the mechanism by which ultrasound excites neurons and to monitor the unveiled mechanism in human subjects. In addition, she will be honored with the 2019 Engineering in Medicine and Biology Society's Technical Achievement Award in Berlin this July for her "outstanding and pioneering contributions in the field of ultrasound imaging and therapy, and their application and clinical translation to the diagnosis of cardiovascular diseases, tumor diagnosis and treatment as well as brain drug delivery and stimulation."

"We all have loved ones with neurodegenerative disorders," Konofagou adds. "My grandmother has been suffering from dementia for more than five years, so I know first-hand how essential it would be to have a simple device that can be wheeled into the patient's home and offer a higher quality of life, especially for our rapidly aging population. And there are so many deadly diseases like brain tumors that affect people of all ages, with no cure yet in sight. That's why we want to bring our research so rapidly to the clinic."
-end-
About the Study

The study is titled "Amelioration of the nigrostriatal pathway facilitated by ultrasound-mediated neurotrophic delivery in early Parkinson's disease."

Authors--all from Columbia University--are: Maria Eleni Karakatsani a,; Shutao Wang a; Gesthimani Samiotaki a; Tara Kugelman a,;Oluyemi O. Olumolade a; Camilo Acosta a; Tao Sun a; Yang Han a; Hermes A.S. Kamimura a; Vernice Jackson-Lewis c, e, f; Serge Przedborski c, d, e, f; Elisa Konofagou a, b, f.
a Department of Biomedical Engineering
b Department of Radiology
c Department of Pathology & Cell Biology
d Department of Neurology
e Center for Motor Neuron Biology and Disease
f Columbia Translational Neuroscience Initiative

The study was supported by the National Institutes of Health, (AG038961, EB009041, NS099862, NS072428, and NS107442), the Focused Ultrasound Foundation, the Kavli Institute, and the Kinetics Foundation.

The authors declare no financial or other conflicts of interest.

LINKS:
Paper: https://www.sciencedirect.com/science/article/pii/S0168365919301907?via%3Dihub
DOI: 10.1016/j.jconrel.2019.03.030
http://engineering.columbia.edu/
https://engineering.columbia.edu/faculty/elisa-konofagou
http://orion.bme.columbia.edu/ueil/
https://www.cuimc.columbia.edu/
https://www.journals.elsevier.com/journal-of-controlled-release
https://bme.columbia.edu/

Columbia Engineering

Columbia Engineering, based in New York City, is one of the top engineering schools in the U.S. and one of the oldest in the nation. Also known as The Fu Foundation School of Engineering and Applied Science, the School expands knowledge and advances technology through the pioneering research of its more than 220 faculty, while educating undergraduate and graduate students in a collaborative environment to become leaders informed by a firm foundation in engineering. The School's faculty are at the center of the University's cross-disciplinary research, contributing to the Data Science Institute, Earth Institute, Zuckerman Mind Brain Behavior Institute, Precision Medicine Initiative, and the Columbia Nano Initiative. Guided by its strategic vision, "Columbia Engineering for Humanity," the School aims to translate ideas into innovations that foster a sustainable, healthy, secure, connected, and creative humanity.

Columbia University School of Engineering and Applied Science

Related Ultrasound Articles:

Ultrasound aligns living cells in bioprinted tissues
Researchers have developed a technique to improve the characteristics of engineered tissues by using ultrasound to align living cells during the biofabrication process.
Ultrasound for thrombosis prevention
Researchers established real-time ultrasonic monitoring of the blood's aggregate state using the in vitro blood flow model.
Ultra ultrasound to transform new tech
A new, more sensitive method to measure ultrasound may revolutionize everything from medical devices to unmanned vehicles.
Shoulder 'brightness' on ultrasound may be a sign of diabetes
A shoulder muscle that appears unusually bright on ultrasound may be a warning sign of diabetes, according to a new study.
Ultrasound-firewall for mobile phones
Mobile phones and tablets through so-called audio tracking, can be used by means of ultrasound to unnoticeably track the behaviour of their users: for example, viewing certain videos or staying in specific rooms and places.
More Ultrasound News and Ultrasound Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...